London, United Kingdom. BIBA Research, the market research specialists for the medical technology industry, have released the Q3 issue of their Transcatheter Heart Valve report, as a part of their long-established European Cardiovascular Monitor (ECVM). The report covers the data period July-September 2009.
The monitor on transcatheter heart valve was launched earlier this year and represents the largest third-part investigation on market trends and penetration of transcatheter heart valve technologies in Western Europe. The monitor tracks quarterly consumption from a panel of 300 hospitals in 15 countries: it provides information on volume of procedures, penetration of transcatheter techniques (transfemoral, transapical, subclavian), and volume of units and turnover of transcatheter heart valve devices.
The transcatheter (or percutaneous) heart valve implantation is considered a technology with enormous clinical potentials. The first implantation of an aortic valve via transfemoral approach in humans was performed by French cardiologist Alain Cribier in 2002. Since then, transcatheter heart valve procedures have recorded constant double-digit growth on year, as an increasing number of centres have introduced this programme, offering a new therapeutic option to candidates not suitable for conventional surgery.
“We are very pleased we have added this service to our long-established market research offering”, said Paul Bristow, director of Consulting Services at BIBA. “This survey stretches throughout an impressive number of institutions, providing valuable information on transcatheter heart valve market dynamics. The aim of this service is to provide clients with key-information for strategic decisions”.
Other services from BIBA Research’s European Cardiovascular Monitor (ECVM) include quarterly surveys on cardiac surgery and coronary stenting in Western, Central and Eastern Europe. Moreover, BIBA continue to lead the vascular and endovascular market research business thanks to their successful monitors on Abdominal Aortic Aneurysms (AAA) and Thoracic Aortic Aneurysms (TAA) covering Western Europe and the United States.
